<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Pan S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Immune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.&lt;h4>Objective&lt;/h4>Multi-machine learning model were constructed to screen the risk factors for irAEs in ICIs for the treatment of HBV-related hepatocellular and build a prediction model for the occurrence of clinical IRAEs.&lt;h4>Methods&lt;/h4>Data from 274 hepatitis B virus positive tumor patients who received PD-1 or/and CTLA4 inhibitor treatment and had immune cell detection results were collected from Henan Cancer Hospital for retrospective analysis. Models were est</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1516524</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11807960</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning.</pubmed_title><pmcid>PMC11807960</pmcid><pubmed_authors>Pan S</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning.</name><description>&lt;h4>Background&lt;/h4>Immune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.&lt;h4>Objective&lt;/h4>Multi-machine learning model were constructed to screen the risk factors for irAEs in ICIs for the treatment of HBV-related hepatocellular and build a prediction model for the occurrence of clinical IRAEs.&lt;h4>Methods&lt;/h4>Data from 274 hepatitis B virus positive tumor patients who received PD-1 or/and CTLA4 inhibitor treatment and had immune cell detection results were collected from Henan Cancer Hospital for retrospective analysis. Models were est</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-04T11:57:12.972Z</modification><creation>2025-04-04T11:57:12.972Z</creation></dates><accession>S-EPMC11807960</accession><cross_references><pubmed>39931579</pubmed><doi>10.3389/fimmu.2024.1516524</doi></cross_references></HashMap>